| abstract |
The present invention relates to compounds of formula (I), or a pharmaceutically acceptable salt thereof. (I) The present invention also relates to processes for the preparation and use of the compounds of formula I, as well as to pharmaceutical compositions containing such compounds. The compounds of formula I are LMP7 inhibitors and may be useful for the treatment of related inflammatory diseases and disorders such as, for example, rheumatoid arthritis, lupus and irritable bowel disease. |